Zepp Health

Zepp Health EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Zepp Health (ZEPP) as of Nov 1, 2026 is -0.27. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -0.18 — a change of 47.63% (lower).

EV/EBIT

-0.27

YoY

47.63%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Zepp Health is 2025 -0.27 . EV/EBIT (Enterprise Value to EBIT) of Zepp Health was 2024 -0.18 . It decreases by 47.63% lower compared to the previous year.

The Zepp Health EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2018
0.18 USD
Jan 1, 2019
0.11 USD
Jan 1, 2020
0.42 USD
Jan 1, 2021
0.74 USD
Jan 1, 2022
-0.16 USD
Jan 1, 2023
-0.33 USD
Jan 1, 2024
-0.18 USD
Jan 1, 2025
-0.27 USD
The Zepp Health EV/EBIT history
YEAREV/EBITYoY
-0.27+47.63%
-0.18-44.69%
-0.33+97.43%
-0.16-122.21%
0.74+77.61%
0.42+275.89%
0.11-38.62%
0.18-53.32%
0.39-92.11%
4.91-395.80%
-1.66—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Zepp Health Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Zepp Health's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Zepp Health's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Zepp Health's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Zepp Health grows earnings faster than its peers.

Zepp Health Stock analysis

What does Zepp Health do? Zepp Health Corporation generates revenue through its consumer brands Amazfit, Zepp Clarity, and Zepp Aura, offering smart wearables and health technology products globally. Its product portfolio includes smart bands, watches, rings, hearables, the Helio Strap, smart scales, and accessories, alongside sportswear and home appliances. The company sells these under the Amazfit and Zepp brand names in around 90 countries, targeting health-conscious individuals seeking fitness and wellness solutions. Zepp Aura provides personalized sound health solutions for emotional regulation and sports performance, integrated with data analysis via Zepp Life and Zepp mobile apps. Zepp Health’s primary customers are consumers interested in optimizing their health and fitness journeys, purchasing devices like smart bands and watches through its branded offerings. The company’s revenue streams include direct sales of hardware products and digital health services, with Zepp Aura serving as a premium service for real-time biometric data analysis. Products are distributed internationally, leveraging the Amazfit and Zepp brand presence in approximately 90 countries. The business model relies on recurring engagement through mobile apps that display activity and biometric data, enhancing user retention and encouraging additional product purchases. Zepp Clarity and Zepp Aura are positioned as high-value services within the health technology ecosystem, complementing the physical hardware sales. The company’s strategy focuses on building a comprehensive wellness platform that integrates wearable devices with personalized health insights. Zepp Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zepp Health stock

EV/EBIT (Enterprise Value to EBIT) of Zepp Health is -0.27 in 2025.

EV/EBIT (Enterprise Value to EBIT) of Zepp Health changed from -0.18 to -0.27, representing a 47.63% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Zepp Health since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Zepp Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Zepp Health

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Zepp Health